Estrogen may eliminate dangerous breast clones when cooperative support falls below a threshold
Estrogen may expand or eliminate dangerous breast cell lineages depending on local cooperative-cell density after deprivation. At matched intracellular estradiol exposure and total epithelial density, failure of reciprocal population reconstruction to transfer the response would reject this mechanism.
Stage of verification
- Hypothesis published2026-10-03
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
The biological function description is being prepared
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Harmful clone
Cooperating dangerous cells in breast tissue
A local population of dangerous breast cells whose descendants depend on survival signals from cooperating cells
Hypotheses on this target 2
Clearance restoration
Elimination1
Immunosuppression
Population balance1
What is proposed
Population balance
Reduce local cell density below the cooperative persistence threshold
With whatPhysical or surgical intervention
HowUse micropatterned organoids to dilute cooperating cells, replacing removed cells with noncooperating epithelial cells while keeping intracellular estradiol exposure matched
From the recordDiluting the same cooperating population below its fitted threshold makes short-deprived lineages decline.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
The work concerns whether changes around menopause, when menstrual periods permanently cease, could reveal ways to separate an immediate benefit from harm that appears later. Its unexpected move is to locate the proposed vulnerability of dangerous breast cells in their dependence on nearby partners: estrogen might promote growth in a sufficiently large cooperating community but accelerate its disappearance below a critical local abundance. This is a hypothesis generated by the pipeline, not a measured result, and its connection to radical lifespan extension remains unestablished.
- Prolonged estrogen deprivation is proposed to reduce the local abundance of cooperating dangerous breast cells.
- Fewer cooperating neighbors are proposed to provide less of the signaling needed for newly produced cells to survive.
- Renewed estrogen is proposed to increase both the production and loss of cells.
- Above a critical local abundance, cooperative support is proposed to let production exceed loss; below it, insufficient support is proposed to let loss exceed production.
- Rebuilding or diluting the cooperating community is predicted to switch growth to decline or decline to growth, even across different donor hormone histories.
A neighborhood workshop can take on more jobs only while enough people remain to help one another finish them. Speeding up work could increase completed jobs in a well-staffed workshop but leave an understaffed one losing workers faster than it replaces them.
Where the picture breaks: Cells do not organize work intentionally. The proposal requires a real survival signal between cells and measured changes in cell production and loss; the workshop picture supplies neither evidence for that signal nor a numerical threshold.
- Master questionstep 01 of 04
Understanding the conditions associated with menopause might provide knowledge relevant to greatly extending human lifespan.
Rests on: The supplied goal identifies menopause-associated conditions as a possible starting point for lifespan research.
AssumptionThe goal assumes that studying these conditions can yield knowledge useful for radical lifespan extension; the supplied material does not establish that connection.
- Goal pillarstep 02 of 04
A response that helps compensate for a bodily change may also cause damage later, so its benefit and delayed harm need to be distinguished.
Rests on: The goal seeks useful knowledge from menopause-associated conditions, but does not identify a particular compensating response or its delayed harm.
AssumptionThe pillar takes separation of compensatory benefit from delayed harm as a useful route toward the lifespan goal. The preceding stage does not supply a mechanism or evidence for that choice.
- Gap questionstep 03 of 04
A long period without estrogen might change later exposure from favoring dangerous breast clones, families of cells descended from a common ancestor, to eliminating them. The question also asks whether equal-exposure comparisons can separate that history effect from differences in hormone preparation, detection, and participant selection.S1
Rests on: The preceding pillar supplies the distinction between benefit and harm. S1, in Cancer Drug Resistance in 2019, describes a breast-cancer treatment-resistance setting in which prolonged exposure to tamoxifen, a drug that alters estrogen signaling, accompanies continued drug-stimulated growth while estradiol, a form of estrogen, induces apoptosis, a regulated process of cell death. That supports the narrower possibility of a history-dependent response; it does not establish the proposed deprivation experiment, elimination of whole cell families, or a cooperative-cell mechanism.
Supported by literature - Hypothesisstep 04 of 04
Dangerous breast-cell families are proposed to need survival signals from cooperating neighbors. After prolonged estrogen deprivation reduces that local community, renewed estrogen is proposed to increase both production and loss of cells: a sufficiently supported community grows, while an insufficiently supported one declines toward disappearance. Rebuilding the cooperating population is predicted to restore growth regardless of the donor's hormone history.
Rests on: The preceding question explicitly leaves open whether deprivation reverses the effect of later estrogen exposure. The endpoint offers a proposed explanation using a strong Allee effect, a population model in which growth becomes negative below a critical local abundance because cooperation is insufficient. This stated model supplies the proposal's basis; it does not establish that breast cells behave this way.
Stated in the chain
What is carried, and what is not. Two screened sources speak to broad ingredients: S1 in Cancer Drug Resistance in 2019 describes estrogen-associated cell death in a particular treatment-resistance setting, without establishing cooperative dependence; S7 in Oncology Letters in 2018 attributes stimulated cancer-cell multiplication to factors released by cells derived from fat tissue, without testing cooperation among dangerous breast clones or estrogen re-exposure. Neither establishes the proposed switch between growth and decline at a critical cooperating-cell abundance, and no supplied source establishes the sequence end to end.S1S7
Where the reasoning is carried by something unstated · 2
- Master question. The goal assumes that studying these conditions can yield knowledge useful for radical lifespan extension; the supplied material does not establish that connection.
- Goal pillar. The pillar takes separation of compensatory benefit from delayed harm as a useful route toward the lifespan goal. The preceding stage does not supply a mechanism or evidence for that choice.
How a result here could mislead · 3
- Growth restored by cooperating cells or conditioned medium, liquid previously exposed to cells and containing substances they released, could be credited to a survival signal when the intervention actually changes estrogen exposure inside the target cells. What closes it: The design requires matched intracellular estradiol exposure, meaning the hormone exposure measured inside cells. That match must hold across reconstructed populations and rescue conditions; conditioned-medium experiments require steroid remeasurement and normalization, as the specification states.
- A falling share of dangerous cells could be mistaken for their elimination if replacement cells simply multiply faster. Likewise, growth at high cooperating-cell abundance and decline at low abundance would not by themselves show that estrogen caused the difference. What closes it: Measure absolute numbers of the tracked dangerous cell families and measure cell production and death independently, as specified. Include the required vehicle comparisons, controls receiving the delivery mixture without added estradiol, at each relevant cooperating-cell abundance. A short decline cannot by itself establish eventual disappearance.
- A rescue after adding cooperating cells could be treated as proof that population support replaces the rival explanations, even if the added cells also correct damage inside the target cells. Conversely, failed rescue could be treated as rejection when the intended local support was never restored. What closes it: Verify that reconstruction changes local cooperating-cell abundance or supplies an experimentally verified survival signal. Test both restoration in long-deprived cells and dilution in short-deprived cells, and determine whether rescue occurs without changing the rival features: cell-division organizing structures, collisions in protein-making machinery, or the integrity of cellular recycling compartments.
What would make this wrong. The decisive contradiction would be failure of verified population reconstruction to transfer the response: restoring adequate local cooperation fails to restore growth in long-deprived cell families, or dilution below the model-predicted boundary fails to make short-deprived families decline, despite matched intracellular estradiol exposure and total cell density. Persistent dependence on donor hormone history under those conditions would contradict the proposal that local cooperative abundance carries the history effect. It would not, by itself, identify which rival mechanism is correct.
What it would change. If the prediction held, prior hormone exposure would affect this breast-cell response through a reconstructable local community, rather than requiring a permanently lethal response within each individual cell. Separating benefit from delayed harm would then require measuring which cooperating cells remain nearby and whether the same exposure promotes their growth or decline. Results in organoids, laboratory-grown three-dimensional cell structures, would still not establish the same behavior in people, its long-term consequences, or any extension of human lifespan.
Sources read · 9
New insights into acquired endocrine resistance of breast cancer. · Cancer drug resistance (Alhambra, Calif.) · 2019
“In phase II, constant exposure to tamoxifen more than 5 years results in continued tamoxifen-stimulated growth, but E 2 induces apoptosis at this stage.”
Does not settle: The source does not establish a cooperative-cell signaling mechanism, a local population-density or ecological persistence threshold, density-dependent reversal between expansion and extinction, increased reproductive activity and turnover after estrogen re-exposure, or whether experimentally reconstructing density reproduces the response regardless of donor history.
Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers. · Cell death & disease · 2018
“We found that Bcl-2/Bcl-xL inhibition did not increase cell death in LTED-selected cells. However, Mcl-1 expression and activity were upregulated upon estrogen deprivation, as well as in response to fulvestrant.”
Does not settle: The source does not test estrogen re-exposure, cooperative signaling or cell-density thresholds, descendant survival, net extinction below a persistence threshold, reconstruction of responses by manipulating local population density, or whether donor endocrine history becomes irrelevant at matched density.
The Eleanor ncRNAs activate the topological domain of the ESR1 locus to balance against apoptosis. · Nature communications · 2019
“Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time”
Does not settle: The supplied text is only a references section. It does not establish cooperative signaling, a population-density threshold, clone extinction or expansion, descendant survival, donor-history independence, experimental reconstruction of density, or the relevant dose, timescale, and conditions.
Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells. · Molecular oncology · 2022
“This MCF7 clone was then subjected to SFM, SFM with 10 n m EE, and fulvestrant treatments, as described above.”
Does not settle: This text does not establish a cooperative population-density threshold, clone persistence or extinction, estrogen-driven reproductive activity or turnover, dependence of descendant survival on signaling from cooperating cells, or whether experimentally reconstructed density reproduces responses independently of donor endocrine history.
AR collaborates with ERα in aromatase inhibitor-resistant breast cancer. · Breast cancer research and treatment · 2014
“AR contributed to ERα transcriptional activity in MCF-7 AR Arom cells, and AR and ERα co-localized in AD + Ana-treated cells, suggesting cooperation between the two receptors.”
Does not settle: The source does not test cooperative support between cell clones, population-density or persistence thresholds, estrogen-driven extinction below such a threshold, descendant survival, turnover, endocrine-history effects, donor-history independence, or reconstruction of the response by experimentally varying local cell density.
CXCL5 secreted from adipose tissue-derived stem cells promotes cancer cell proliferation. · Oncology letters · 2018
“The ASC-secreted factors were most likely responsible for the stimulatory effect on tumor cell proliferation.”
Does not settle: This source does not test estrogen deprivation or re-exposure, an ecological persistence threshold, clone extinction, cooperative cancer-cell density, endocrine history, descendant survival, or whether reconstructing local density reproduces the response.
“In this sense, co-targeting HER2 and ER may therefore help to optimize survival outcomes for patients with HER2+, ER+ BC; the heredERA BC study is aiming to address this unmet need by evaluating the combination of PH FDC SC with giredestrant as maintenance therapy”
Does not settle: The source does not test estrogen deprivation or re-exposure, cooperative signaling or cell-density effects, an ecological persistence threshold, clone extinction, descendant survival, donor endocrine history, or experimental reconstruction of the proposed response.
Life following aromatase inhibitors--where now for endocrine sequencing? · Breast cancer research and treatment · 2005
“Data from in vitro models have suggested that acquired AI resistance is due to enhanced sensitization to low estrogen levels during long-term estrogen deprivation (LTED).”
Does not settle: The abstract does not test estrogen re-exposure, cooperative clone density, an ecological persistence threshold, descendant survival, net extinction, donor-history independence, or any threshold-defining experiment.
Evidence for Enhanced Exosome Production in Aromatase Inhibitor-Resistant Breast Cancer Cells. · International journal of molecular sciences · 2020
“We found that exosome secretion was significantly increased in MCF-7 LTED cells compared to MCF-7 cells.”
Does not settle: The source does not test estrogen re-exposure, cooperative cell density, an ecological persistence threshold, clone extinction or expansion, descendant survival, turnover, donor-history independence, or whether experimentally reconstructing local density reconstructs the response.
The gap this hypothesis explains
Two established results predict opposite outcomes, and both cannot be right.
Does prolonged estrogen withdrawal switch dangerous breast cell groups from expansion to elimination when later exposure is identical?
Original wording · exactly as the pipeline generated it
Does prolonged estrogen deprivation reverse subsequent exposure from selecting dangerous breast clones to eliminating them, and can matched-exposure experiments distinguish this history effect from formulation, detection and participant-selection effects?
What this question is asking
The question concerns whether a long period with little estrogen changes how potentially cancerous groups of breast cells respond when estrogen returns. It asks whether later exposure favors those groups or eliminates them, comparing different exposure histories while holding the later hormone exposure equal. It also asks whether such comparisons can separate an effect of history from differences in hormone preparation, how disease is detected, and which participants enter a study. The question assumes that estrogen can initially favor dangerous groups and draws on reports that some previously deprived breast cancer cells instead die after estrogen returns; whether these observations establish a reversal in people is part of what needs auditing.
- Estrogen and estradiol
- Estrogen names a class of hormones; estradiol is a particular member used in several supplied studies. In these sources, estrogen-related responses include both cell multiplication and programmed cell death, depending on the cellular setting.
- Estrogen deprivation or withdrawal
- A period with reduced estrogen availability. Its duration and biological setting can vary, so laboratory deprivation, hormone-blocking treatment, and menopause are not established here as interchangeable conditions.
- Breast clone and clonal selection
- A clone is a group of breast cells descended from a common starting cell. Selection means that conditions favor some groups' survival or multiplication relative to others; it does not necessarily mean creating new harmful cells.
- Dangerous breast cell group
- The question's label for cells capable of contributing to cancer. The supplied material gives no shared test or threshold defining which groups qualify as dangerous.
- Proliferation
- An increase in cell number through cell division. It is the growth response that the question contrasts with cell death.
- Apoptosis
- A regulated process through which a cell dies. Increased apoptosis in a cell population does not by itself demonstrate elimination of an entire dangerous clone.
- Hormone-blocking treatment and acquired resistance
- Hormone-blocking treatment reduces hormone production or interferes with hormone action. Acquired resistance means cancer cells become less responsive to that treatment over time; the supplied sources describe some resistant cells as vulnerable to renewed estrogen exposure.
- Estrogen receptor
- A cellular protein through which estrogen can influence cell activity. S6 places the receptor in the nucleus, the compartment containing genetic material, at the start of the stress response associated with estrogen-induced death.
- Cellular stress response and inflammation
- A cellular stress response is a change in cell activity when normal functioning is challenged. Inflammation is a tissue response to injury or disturbance; S1 refers to proteins associated with these processes when describing the change in estrogen response.
- MCF-7 and cell models
- MCF-7 is the name of a breast cancer cell line grown for laboratory research. Related groups derived from it can develop different responses, and findings in those cells do not by themselves establish responses in normal breast tissue.
- Menopause and menopausal status
- Menopause is the life transition when menstrual cycles permanently end. Menopausal status describes a person's position relative to that transition; S5 identifies it as relevant to successful estrogen treatment.
- Matched exposure and hormone history
- Matched exposure means holding later hormone treatment conditions equal in the comparison. Hormone history means earlier exposure, deprivation, or treatment; separating people into history groups does not by itself establish that history caused a difference.
- Formulation, detection, and participant-selection effects
- Formulation effects arise from differences in the hormone preparation being compared. Detection effects arise from differences in finding disease, while participant-selection effects arise from differences in who enters a study; each could affect observed outcomes without establishing a causal effect of prior deprivation.
- Follow-up and clinical outcomes
- Follow-up is observation over time after an initial treatment or measurement. Clinical outcomes concern what happens in people, such as later cancer occurrence, rather than only changes in laboratory cell growth or death.
Estrogen exposure initially selects dangerous breast clones, while prolonged estrogen deprivation can change the subsequent response from growth to apoptosis.
Estrogen is a hormone, and a breast clone is a group of cells descended from one starting cell. The assumption is that estrogen first favors potentially harmful groups, but a long period without it changes those cells so that renewed exposure makes them die. If established in the relevant breast tissue, this would make prior exposure history a possible explanation for opposite responses to later estrogen.
S1 reports a switch from growth to programmed cell death after long-term treatment that blocks hormone action, and S7 and S8 report death responses in estrogen-deprived breast cancer cell models. S5 reports that successful estrogen treatment depends on withdrawal duration and menopausal status, but only its abstract was supplied. These findings support the narrower claim that certain adapted breast cancer cells can die after estrogen exposure. They do not establish an initial phase of dangerous-clone selection, a causal reversal of that selection in patients, or the same response in normal breast tissue after menopause. The supplied sources also do not substantiate the pipeline's assertion that clinical estimates differ by study design.S1S5S7S8
The same question asked without the part nothing read establishes:
- With later estrogen exposure held equal, how does prior deprivation affect the survival and expansion of potentially dangerous breast cell groups?
- Do differences associated with prior estrogen deprivation persist when hormone preparation, disease detection, and participant selection are accounted for?
- History reverses expansion into elimination If established, prolonged deprivation would change the cells' response so that otherwise growth-favoring estrogen exposure instead removes the dangerous groups. Exposure history would then change the direction of the response, although lasting protection would still require evidence that those groups remain absent during exposure and later follow-up.
- History does not reverse the response If dangerous groups continue to survive or expand after deprivation, death responses in selected laboratory cells would not establish elimination in the breast tissue at issue. Prior withdrawal could not then be treated as evidence that later estrogen exposure changes from harmful selection to protection.
- Responses differ among cell groups or over time If estrogen kills some groups while others survive or expand, an early reduction in cell growth could coexist with persistence of dangerous cells. In that case, early benefit would not by itself establish the direction of harm over subsequent years.
If estrogen favors the survival or multiplication of dangerous breast cell groups, those groups could become more prominent during exposure. If previous deprivation instead makes those cells die when estrogen returns, the same later exposure could have a different consequence. However, death among some cells does not establish elimination of every dangerous group or protection over subsequent years. Treating a short-term response as proof of lasting protection could therefore mischaracterize delayed harm, while assuming that estrogen always promotes growth could miss the death response reported in particular breast cancer models.
RL-2 clinical estimates differ by design; RL-1 deprivation models predict apoptosis rather than growth, without validation in normal menopausal breast tissue.
Within each endocrine-history stratum, early benefit must remain separated from proliferative harm throughout exposure and years of follow-up.
Whether deprivation causally reverses clonal selection remains unknown, preventing determination of whether exposure history changes the direction of delayed harm.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
CROSS-DOMAIN TRANSFER: Deprivation reverses the effect of estrogen by pushing cooperating dangerous clones below an ecological persistence threshold. Re-exposure increases both reproductive activity and turnover, but successful survival of descendants requires sufficient signaling from cooperating cells. Above the threshold, estrogen expands the community; below it, estrogen accelerates net extinction because cooperative support is insufficient. Individual cells need not acquire an intrinsically lethal estrogen response. The endocrine history is expressed through local cooperative population density, and experimentally reconstructing that density should reconstruct the response regardless of donor history. Defining this threshold would help stabilize SPV_7 by identifying when an apparently protective exposure instead supports expansion.
Where the idea comes from
The hypothesis borrows a result from another field. This is what it borrows, and from where.
Population and community ecology: a strong Allee-effect model generated by cooperative survival, dN/dt = N[b(E)N/(A+N) - d(E)]. N is local density of the cooperating dangerous population; t is time; E is measured intracellular estradiol exposure; b(E) is the maximal per-cell production rate of surviving descendants under saturating cooperation; A is the density giving half-maximal cooperative support; d(E) is per-cell loss rate. For b(E)>d(E), the unstable persistence threshold is N_c(E)=A d(E)/[b(E)-d(E)]. The hypothesis requires, and does not assume as established, that estrogen produces negative net growth below this threshold and positive growth above it, with the corresponding vehicle contrasts measured. The equation applies over the short experimental interval before crowding limits growth.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
At identical intracellular estradiol exposure and total epithelial density, changing the local abundance of cooperating dangerous cells produces a reproducible sign change in their absolute net growth. Reconstituting cooperating cells, or their experimentally verified survival signal, rescues long-deprived lineages without altering their centrosomes, ribosomal collision response or lysosomal integrity. Diluting the same cooperating population below its fitted threshold makes short-deprived lineages decline. Failure of reciprocal population reconstruction to transfer the response rejects this IH in favor of a cell-intrinsic mechanism.
Would tell it apart from at least one rival. The prediction specifies an observable growth-sign change under controlled conditions and an explicit rejection condition. No rival prediction is supplied. A paper already fetched for this hypothesis bears on it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Micropatterned organoids can vary cooperating-cell density while replacing removed cells with noncooperating epithelial cells to preserve total density. Measure birth and death independently and fit the model on training conditions before predicting held-out mixtures. Conditioned-medium rescue requires steroid remeasurement and normalization.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
At identical intracellular estradiol exposure and total epithelial density, changing the local abundance of cooperating dangerous cells produces a reproducible sign change in their absolute net growth. Reconstituting cooperating cells, or their experimentally verified survival signal, rescues long-deprived lineages without altering their centrosomes, ribosomal collision response or lysosomal integrity. Diluting the same cooperating population below its fitted threshold makes short-deprived lineages decline. Failure of reciprocal population reconstruction to transfer the response rejects this IH in favor of a cell-intrinsic mechanism.
- Rival 01 of 03What would separate them
Estrogen re-exposure may eliminate dangerous breast clones through abnormal spindle geometry predicts: In sister cultures randomized to different deprivation durations, irreversible lineage loss occurs predominantly after directly observed multipolar mitoses. Correcting centrosome number or restoring bipolar spindle assembly preserves long-term clonogenic survival despite unchanged intracellular estradiol and receptor activation. Conversely, introducing the corresponding centrosomal abnormality into short-deprived cells reproduces susceptibility. Death before mitosis, or continued elimination after verified spindle correction, rejects this explanation in favor of the ribosomal or lysosomal rivals.
- Rival 02 of 03What would separate them
Estrogen re-exposure may kill deprived breast cell lineages through ribosome collisions predicts: Deprived lineages show a re-exposure-specific increase in collided-ribosome footprints followed by ZAKα–p38/JNK activation before their first mitosis or lysosomal leakage. ZAKα disruption preserves clonogenic survival despite persistent collision footprints and matched estrogen signaling; wild-type ZAKα restores killing, whereas a collision-sensing-defective construct does not. Equalizing cooperative-cell density does not rescue. Absence of the predicted collision sequence, or failure of selective ZAKα disruption to rescue, favors the other IHs.
- Rival 03 of 03What would separate them
Estrogen re-exposure may kill breast cell lineages by rupturing deprivation-altered lysosomes predicts: During matched re-exposure, lysosomal leakage and cytosolic cathepsin activity precede mitochondrial permeabilization, caspase activation and the first mitosis. Independently validated suppression of the responsible cathepsins or prevention of lysosomal rupture restores post-washout clonogenic survival, whereas ZAKα disruption, spindle correction and cooperative-population reconstruction do not. Executioner-caspase inhibition alone fails to preserve the lineage. Leakage only after another death pathway activates, or failure of lysosome-specific rescue, rejects this initiating mechanism.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. 5 paper(s) already retrieved for this hypothesis carry its prediction’s terms. Reading them comes before running anything. Already retrieved: Equity-Preserving Public Health Resource Allocation Using Multi-Objective Safe Reinforcement Learning: Evidence from Thailand.; Bio-RegNet: A Meta-Homeostatic Bayesian Neural Network Framework Integrating Treg-Inspired Immunoregulation and Autophagic Optimization for Adaptive Community Detection and Stable Intelligence.; Advancing resilience science through cross-domain integration: Proceedings of an NIH workshop..
6 papers retrieved around this hypothesis
- Advancing resilience science through cross-domain integration: Proceedings of an NIH workshop.PMID 41887477 · full_text · 120,570 characters stored
- Evidence Drift in Early Childhood Caries Research: A Conceptual Six-Domain Causal-Translation Framework.PMID 42650391 · full_text · 62,613 characters stored
- Unpacking the within-person and between-person dynamics of physical activity and bedtime procrastination: a random intercept cross-lagged mediation model of self-control.PMID 42471667 · full_text · 62,522 characters stored
- Enhanced Health Study Discoverability: Graph-Based Analysis Approach.PMID 42611793 · full_text · 74,625 characters stored
- Equity-Preserving Public Health Resource Allocation Using Multi-Objective Safe Reinforcement Learning: Evidence from Thailand.PMID 42512190 · full_text · 152,669 characters stored
- Bio-RegNet: A Meta-Homeostatic Bayesian Neural Network Framework Integrating Treg-Inspired Immunoregulation and Autophagic Optimization for Adaptive Community Detection and Stable Intelligence.PMID 41589965 · full_text · 102,253 characters stored
0 citation handles extracted; 1 Europe PMC search run; 8 records examined; 6 sources stored for enrichment, 6 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.